ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Food Hypersensitivity
Genetic Skin Diseases

Eczema trials near Dallas, TX, USA:

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) (GX-03 in AD)

of GX-03 topical ointment in adult subjects with atopic dermatitis (eczema).Stage 1 (Completed):Stage 1 comprised an initial cohort of 50 su...

Enrolling
Eczema Atopic Dermatitis
Eczema
Combination Product: GX-03
Other: Vehicle

Phase 2, Phase 3

Turn Therapeutics

Irving, Texas, United States

in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema (also called atopic dermatitis) is a common sk...

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: Tilrekimig

Phase 3

Pfizer
Pfizer

Dallas, Texas, United States and 20 other locations

in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itchin...

Enrolling
Atopic Dermatitis
Drug: Tilrekimig
Drug: Dupilumab

Phase 3

Pfizer
Pfizer

Dallas, Texas, United States and 31 other locations

The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...

Invitation-only
Atopic Dermatitis Eczema
Eczema
Drug: IMG-007

Phase 2

Inmagene

Southlake, Texas, United States and 22 other locations

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Enrolling
Atopic Dermatitis Eczema
Eczema
Drug: Placebo
Drug: IMG-007

Phase 2

Inmagene

Southlake, Texas, United States and 39 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

Frisco, Texas, United States and 27 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

Dallas, Texas, United States and 88 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Dallas, Texas, United States and 60 other locations

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Active, not recruiting
Atopic Dermatitis
Biological: Barzolvolimab
Drug: Matching placebo

Phase 2

Celldex Therapeutics
Celldex Therapeutics

Dallas, Texas, United States and 36 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Active, not recruiting
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

Dallas, Texas, United States and 100 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems